Do analysts rate BIRD or ALP?

Portage Biotech has a consensus price target of $12.50, indicating a potential upside of 124.01%. Given Portage Biotech's stronger consensus rating and higher probable upside, analysts plainly believe Portage Biotech is more favorable than Allbirds. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Allbirds 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 Portage Biotech 1 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.67

Does the media refer more to BIRD or ALP?

In the previous week, Portage Biotech had 2 more articles in the media than Allbirds. MarketBeat recorded 7 mentions for Portage Biotech and 5 mentions for Allbirds. Portage Biotech's average media sentiment score of 0.71 beat Allbirds' score of 0.67 indicating that Portage Biotech is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Allbirds 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Portage Biotech 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts rate ALP or AZIO?

Portage Biotech currently has a consensus target price of $12.50, suggesting a potential upside of 124.01%. Given Portage Biotech's stronger consensus rating and higher probable upside, equities analysts plainly believe Portage Biotech is more favorable than Envirotech Vehicles. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Portage Biotech 1 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.67 Envirotech Vehicles 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Does the media refer more to ALP or AZIO?

In the previous week, Portage Biotech had 5 more articles in the media than Envirotech Vehicles. MarketBeat recorded 7 mentions for Portage Biotech and 2 mentions for Envirotech Vehicles. Envirotech Vehicles' average media sentiment score of 0.89 beat Portage Biotech's score of 0.71 indicating that Envirotech Vehicles is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Portage Biotech 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Envirotech Vehicles 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer ALP or IPM?

Portage Biotech presently has a consensus target price of $12.50, suggesting a potential upside of 124.01%. Given Portage Biotech's stronger consensus rating and higher probable upside, research analysts clearly believe Portage Biotech is more favorable than Intelligent Protection Management. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Portage Biotech 1 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.67 Intelligent Protection Management 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50

Which has higher earnings & valuation, BRUN or ALP?

Boost Run has higher revenue and earnings than Portage Biotech. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Boost Run $56.42M N/A N/A N/A N/A Portage Biotech $97K 89.16 -$38.63M -$409.00 N/A

Is BRUN or ALP more profitable?

Company Net Margins Return on Equity Return on Assets Boost Run N/A N/A N/A Portage Biotech N/A N/A N/A

Does the media refer more to BRUN or ALP?

In the previous week, Portage Biotech had 2 more articles in the media than Boost Run. MarketBeat recorded 7 mentions for Portage Biotech and 5 mentions for Boost Run. Boost Run's average media sentiment score of 0.98 beat Portage Biotech's score of 0.71 indicating that Boost Run is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Boost Run 1 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Portage Biotech 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer ALP or ALIS?

Portage Biotech presently has a consensus target price of $12.50, suggesting a potential upside of 124.01%. Given Portage Biotech's stronger consensus rating and higher probable upside, analysts clearly believe Portage Biotech is more favorable than Calisa Acquisition. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Portage Biotech 1 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.67 Calisa Acquisition 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has higher valuation & earnings, ALP or ALIS?

Calisa Acquisition has lower revenue, but higher earnings than Portage Biotech. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Portage Biotech $97K 89.16 -$38.63M -$409.00 N/A Calisa Acquisition N/A N/A N/A N/A N/A

Is ALP or ALIS more profitable?

Company Net Margins Return on Equity Return on Assets Portage Biotech N/A N/A N/A Calisa Acquisition N/A N/A N/A

Does the media refer more to ALP or ALIS?

In the previous week, Portage Biotech had 5 more articles in the media than Calisa Acquisition. MarketBeat recorded 7 mentions for Portage Biotech and 2 mentions for Calisa Acquisition. Calisa Acquisition's average media sentiment score of 0.91 beat Portage Biotech's score of 0.71 indicating that Calisa Acquisition is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Portage Biotech 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Calisa Acquisition 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Portage Biotech (ALP) Competitors

$5.58 -0.03 (-0.53%)

As of 09/25/2026 04:00 PM Eastern

Compare

ALP vs. BIRD, AZIO, IPM, BRUN, and ALIS

Should you buy Portage Biotech stock or one of its competitors? Portage Biotech's main competitors and comparable companies include Allbirds (BIRD), Envirotech Vehicles (AZIO), Intelligent Protection Management (IPM), Boost Run (BRUN), and Calisa Acquisition (ALIS). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "internet services & infrastructure" industry.

How does Portage Biotech compare to Allbirds?

Allbirds (NASDAQ:BIRD) and Portage Biotech (NASDAQ:ALP) are both small-cap technology companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, valuation, institutional ownership, risk, profitability, dividends, analyst recommendations and media sentiment.

Portage Biotech has a net margin of 0.00% compared to Allbirds' net margin of -72.82%. Portage Biotech's return on equity of 0.00% beat Allbirds' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Allbirds	-72.82%	-231.86%	-81.53%
Portage Biotech	N/A	N/A	N/A

Portage Biotech has lower revenue, but higher earnings than Allbirds. Allbirds is trading at a lower price-to-earnings ratio than Portage Biotech, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Allbirds	$155.22M	0.13	-$77.28M	-$8.99	N/A
Portage Biotech	$97K	89.16	-$38.63M	-$409.00	N/A

Allbirds has a beta of 2.62, suggesting that its stock price is 162% more volatile than the broader market. Comparatively, Portage Biotech has a beta of 0.54, suggesting that its stock price is 46% less volatile than the broader market.

In the previous week, Portage Biotech had 2 more articles in the media than Allbirds. MarketBeat recorded 7 mentions for Portage Biotech and 5 mentions for Allbirds. Portage Biotech's average media sentiment score of 0.71 beat Allbirds' score of 0.67 indicating that Portage Biotech is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Allbirds	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Portage Biotech	1 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Portage Biotech has a consensus price target of $12.50, indicating a potential upside of 124.01%. Given Portage Biotech's stronger consensus rating and higher probable upside, analysts plainly believe Portage Biotech is more favorable than Allbirds.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Allbirds	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Portage Biotech	1 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.67

44.1% of Allbirds shares are owned by institutional investors. Comparatively, 13.4% of Portage Biotech shares are owned by institutional investors. 18.8% of Allbirds shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

Portage Biotech beats Allbirds on 10 of the 15 factors compared between the two stocks.

How does Portage Biotech compare to Envirotech Vehicles?

Portage Biotech (NASDAQ:ALP) and Envirotech Vehicles (NASDAQ:AZIO) are both small-cap technology companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, media sentiment, earnings, dividends, analyst recommendations, risk, valuation and institutional ownership.

13.4% of Portage Biotech shares are held by institutional investors. Comparatively, 5.7% of Envirotech Vehicles shares are held by institutional investors. 17.8% of Envirotech Vehicles shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

In the previous week, Portage Biotech had 5 more articles in the media than Envirotech Vehicles. MarketBeat recorded 7 mentions for Portage Biotech and 2 mentions for Envirotech Vehicles. Envirotech Vehicles' average media sentiment score of 0.89 beat Portage Biotech's score of 0.71 indicating that Envirotech Vehicles is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Portage Biotech	1 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Envirotech Vehicles	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Portage Biotech currently has a consensus target price of $12.50, suggesting a potential upside of 124.01%. Given Portage Biotech's stronger consensus rating and higher probable upside, equities analysts plainly believe Portage Biotech is more favorable than Envirotech Vehicles.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Portage Biotech	1 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.67
Envirotech Vehicles	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Portage Biotech has a beta of 0.54, suggesting that its share price is 46% less volatile than the broader market. Comparatively, Envirotech Vehicles has a beta of 0.87, suggesting that its share price is 13% less volatile than the broader market.

Portage Biotech has higher earnings, but lower revenue than Envirotech Vehicles. Envirotech Vehicles is trading at a lower price-to-earnings ratio than Portage Biotech, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Portage Biotech	$97K	89.16	-$38.63M	-$409.00	N/A
Envirotech Vehicles	$5.94M	3.55	-$39.13M	-$4.90	N/A

Portage Biotech has a net margin of 0.00% compared to Envirotech Vehicles' net margin of -331.76%. Portage Biotech's return on equity of 0.00% beat Envirotech Vehicles' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Portage Biotech	N/A	N/A	N/A
Envirotech Vehicles	-331.76%	-1,284.22%	-219.83%

Summary

Portage Biotech beats Envirotech Vehicles on 10 of the 15 factors compared between the two stocks.

How does Portage Biotech compare to Intelligent Protection Management?

Portage Biotech (NASDAQ:ALP) and Intelligent Protection Management (NASDAQ:IPM) are both small-cap technology companies, but which is the better business? We will compare the two companies based on the strength of their dividends, profitability, valuation, institutional ownership, risk, earnings, media sentiment and analyst recommendations.

Portage Biotech presently has a consensus target price of $12.50, suggesting a potential upside of 124.01%. Given Portage Biotech's stronger consensus rating and higher probable upside, research analysts clearly believe Portage Biotech is more favorable than Intelligent Protection Management.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Portage Biotech	1 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.67
Intelligent Protection Management	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

Portage Biotech has a net margin of 0.00% compared to Intelligent Protection Management's net margin of -14.80%. Portage Biotech's return on equity of 0.00% beat Intelligent Protection Management's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Portage Biotech	N/A	N/A	N/A
Intelligent Protection Management	-14.80%	-21.13%	-13.41%

In the previous week, Portage Biotech had 6 more articles in the media than Intelligent Protection Management. MarketBeat recorded 7 mentions for Portage Biotech and 1 mentions for Intelligent Protection Management. Intelligent Protection Management's average media sentiment score of 0.93 beat Portage Biotech's score of 0.71 indicating that Intelligent Protection Management is being referred to more favorably in the news media.

Company	Overall Sentiment
Portage Biotech	Positive
Intelligent Protection Management	Positive

Intelligent Protection Management has higher revenue and earnings than Portage Biotech. Intelligent Protection Management is trading at a lower price-to-earnings ratio than Portage Biotech, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Portage Biotech	$97K	89.16	-$38.63M	-$409.00	N/A
Intelligent Protection Management	$23.61M	0.70	-$1.96M	-$0.28	N/A

13.4% of Portage Biotech shares are held by institutional investors. Comparatively, 3.9% of Intelligent Protection Management shares are held by institutional investors. 20.8% of Intelligent Protection Management shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Portage Biotech has a beta of 0.54, suggesting that its share price is 46% less volatile than the broader market. Comparatively, Intelligent Protection Management has a beta of 0.46, suggesting that its share price is 54% less volatile than the broader market.

Summary

Portage Biotech beats Intelligent Protection Management on 10 of the 15 factors compared between the two stocks.

How does Portage Biotech compare to Boost Run?

Boost Run (NASDAQ:BRUN) and Portage Biotech (NASDAQ:ALP) are both technology companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, profitability, dividends, valuation, analyst recommendations, media sentiment, risk and earnings.

Company	Net Margins	Return on Equity	Return on Assets
Boost Run	N/A	N/A	N/A
Portage Biotech	N/A	N/A	N/A

13.4% of Portage Biotech shares are held by institutional investors. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

In the previous week, Portage Biotech had 2 more articles in the media than Boost Run. MarketBeat recorded 7 mentions for Portage Biotech and 5 mentions for Boost Run. Boost Run's average media sentiment score of 0.98 beat Portage Biotech's score of 0.71 indicating that Boost Run is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Boost Run	1 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Portage Biotech	1 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Boost Run has higher revenue and earnings than Portage Biotech.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Boost Run	$56.42M	N/A	N/A	N/A	N/A
Portage Biotech	$97K	89.16	-$38.63M	-$409.00	N/A

Boost Run currently has a consensus target price of $42.75, suggesting a potential upside of 154.92%. Portage Biotech has a consensus target price of $12.50, suggesting a potential upside of 124.01%. Given Boost Run's stronger consensus rating and higher possible upside, equities research analysts clearly believe Boost Run is more favorable than Portage Biotech.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Boost Run	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.60
Portage Biotech	1 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.67

Summary

Boost Run beats Portage Biotech on 5 of the 7 factors compared between the two stocks.

How does Portage Biotech compare to Calisa Acquisition?

Portage Biotech (NASDAQ:ALP) and Calisa Acquisition (NASDAQ:ALIS) are both technology companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, valuation, institutional ownership, earnings, analyst recommendations, risk, media sentiment and profitability.

Portage Biotech presently has a consensus target price of $12.50, suggesting a potential upside of 124.01%. Given Portage Biotech's stronger consensus rating and higher probable upside, analysts clearly believe Portage Biotech is more favorable than Calisa Acquisition.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Portage Biotech	1 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.67
Calisa Acquisition	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Calisa Acquisition has lower revenue, but higher earnings than Portage Biotech.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Portage Biotech	$97K	89.16	-$38.63M	-$409.00	N/A
Calisa Acquisition	N/A	N/A	N/A	N/A	N/A

In the previous week, Portage Biotech had 5 more articles in the media than Calisa Acquisition. MarketBeat recorded 7 mentions for Portage Biotech and 2 mentions for Calisa Acquisition. Calisa Acquisition's average media sentiment score of 0.91 beat Portage Biotech's score of 0.71 indicating that Calisa Acquisition is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Portage Biotech	1 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Calisa Acquisition	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Company	Net Margins	Return on Equity	Return on Assets
Portage Biotech	N/A	N/A	N/A
Calisa Acquisition	N/A	N/A	N/A

13.4% of Portage Biotech shares are owned by institutional investors. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Summary

Portage Biotech beats Calisa Acquisition on 5 of the 6 factors compared between the two stocks.

Get Portage Biotech News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ALP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ALP vs. The Competition

Export

Metric	Portage Biotech	IT Services Industry	Technology Sector	NASDAQ Exchange
Market Cap	$8.65M	$10.97B	$31.24B	$13.17B
Dividend Yield	N/A	2.90%	2.76%	14.03%
P/E Ratio	-0.01	14.13	79.31	25.78
Price / Sales	89.16	62.63	586.41	92.85
Price / Cash	N/A	44.05	48.91	52.89
Price / Book	0.40	8.28	7.93	6.30
Net Income	-$38.63M	$271.17M	$704.26M	$360.35M
7 Day Performance	20.00%	-0.81%	1.10%	-0.23%
1 Month Performance	-36.73%	-4.02%	-2.96%	-4.16%
1 Year Performance	N/A	20.79%	180.11%	4.58%

Portage Biotech Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ALP Portage Biotech	4.106 of 5 stars	$5.58 -0.5%	$12.50 +124.0%	-98.1%	$8.65M	$97K	N/A	6	News Coverage Short Interest Decrease
BIRD Allbirds	0.9661 of 5 stars	$2.37 +0.4%	N/A	-59.6%	$20.74M	$152.47M	N/A	710	Analyst Upgrade
AZIO Envirotech Vehicles	0.1525 of 5 stars	$1.20 +2.1%	N/A	-32.3%	$19.35M	$5.94M	N/A	10
IPM Intelligent Protection Management	2.0682 of 5 stars	$1.81 -1.1%	N/A	-9.0%	$16.53M	$23.61M	N/A	20	News Coverage Gap Up
BRUN Boost Run	4.0982 of 5 stars	$15.16 +11.7%	$45.00 +196.8%	N/A	$0.00	$56.42M	N/A	N/A	High Trading Volume

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:ALP) was last updated on 9/27/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Portage Biotech (ALP) Competitors

ALP vs. BIRD, AZIO, IPM, BRUN, and ALIS

How does Portage Biotech compare to Allbirds?

Summary

How does Portage Biotech compare to Envirotech Vehicles?

Summary

How does Portage Biotech compare to Intelligent Protection Management?

Summary

How does Portage Biotech compare to Boost Run?

Summary

How does Portage Biotech compare to Calisa Acquisition?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ALP vs. The Competition

Portage Biotech Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Portage Biotech (ALP) Competitors

ALP vs. BIRD, AZIO, IPM, BRUN, and ALIS

How does Portage Biotech compare to Allbirds?

Is BIRD or ALP more profitable?

Which has stronger earnings and valuation, BIRD or ALP?

Which has more volatility and risk, BIRD or ALP?

Does the media refer more to BIRD or ALP?

Do analysts rate BIRD or ALP?

Do insiders and institutionals have more ownership in BIRD or ALP?

Summary

How does Portage Biotech compare to Envirotech Vehicles?

Do insiders & institutionals hold more shares of ALP or AZIO?

Does the media refer more to ALP or AZIO?

Do analysts rate ALP or AZIO?

Which has more volatility & risk, ALP or AZIO?

Which has better earnings and valuation, ALP or AZIO?

Is ALP or AZIO more profitable?

Summary

How does Portage Biotech compare to Intelligent Protection Management?

Do analysts prefer ALP or IPM?

Is ALP or IPM more profitable?

Does the media prefer ALP or IPM?

Which has stronger earnings & valuation, ALP or IPM?

Do insiders and institutionals have more ownership in ALP or IPM?

Which has more volatility & risk, ALP or IPM?

Summary

How does Portage Biotech compare to Boost Run?

Is BRUN or ALP more profitable?

Do insiders & institutionals have more ownership in BRUN or ALP?

Does the media refer more to BRUN or ALP?

Which has higher earnings & valuation, BRUN or ALP?

Do analysts rate BRUN or ALP?

Summary

How does Portage Biotech compare to Calisa Acquisition?

Do analysts prefer ALP or ALIS?

Which has higher valuation & earnings, ALP or ALIS?

Does the media refer more to ALP or ALIS?

Is ALP or ALIS more profitable?

Do institutionals & insiders have more ownership in ALP or ALIS?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ALP vs. The Competition

Portage Biotech Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools